![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Pharmaceutical Sciences, College of Pharmacy, The University of Arizona, Tucson, Arizona
The functionality of the correction factors, maximum life-span potential (MLP), and brain weight (BrW) used in allometry is mathematically described. Correction by MLP or BrW is equivalent to a multiplication of some constants by the predicted values in humans from simple allometry, but they have no relationship to measured pharmacokinetic parameters in the animal species. The values of these constants (FMLP or FBrW) were calculated for some commonly used combinations of animal species. For all combinations of animal species, the value of FBrW is always greater than that of FMLP with a fold-increase of about 1.3 to 1.9. Different combinations of species give different values of FBrW and FMLP. In addition, the role of correction factors (MLP and BrW) or the "rule of exponents" (ROE) was evaluated. An intrinsic defect in using correction factors or ROE was revealed; different study designs will produce significantly different prediction results. However, ROE may still serve as a useful practical approach in predicting human CL since it was derived from real observations and has been applied to many examples.
This article has been cited by other articles:
![]() |
H. Tang, A. Hussain, M. Leal, M. Mayersohn, and E. Fluhler Interspecies Prediction of Human Drug Clearance Based on Scaling Data from One or Two Animal Species Drug Metab. Dispos., October 1, 2007; 35(10): 1886 - 1893. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Evans, L. J. Jolivette, R. Nagilla, and K. W. Ward EXTRAPOLATION OF PRECLINICAL PHARMACOKINETICS AND MOLECULAR FEATURE ANALYSIS OF "DISCOVERY-LIKE" MOLECULES TO PREDICT HUMAN PHARMACOKINETICS Drug Metab. Dispos., July 1, 2006; 34(7): 1255 - 1265. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Mahmood COMMENTS ON "A MATHEMATICAL DESCRIPTION OF THE FUNCTIONALITY OF CORRECTION FACTORS USED IN ALLOMETRY FOR PREDICTING HUMAN DRUG CLEARANCE" Drug Metab. Dispos., March 1, 2006; 34(3): 507 - 509. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tang and M. Mayersohn RESPONSE TO COMMENTS ON "A MATHEMATICAL DESCRIPTION OF THE FUNCTIONALITY OF CORRECTION FACTORS USED IN ALLOMETRY FOR PREDICTING HUMAN DRUG CLEARANCE" Drug Metab. Dispos., March 1, 2006; 34(3): 510 - 511. [Full Text] [PDF] |
||||